Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Oxigene Jumps 30%, Remains a Buy + BioScrip Advances +10% in Past Two Sessions ===> Rx

|Includes: BIOS, Mateon Therapeutics, Inc. (MATN)
Just Posted at Rx Investors

Regarding OXGN, refer to *** 8 Strong Buys *** posted here at SA back on July 8, 2010.

Regarding BIOS, refer to *** BioScrip Sell-Off Presnets a Good Opportunity for Investors *** posted at Rx Investors on July 31, 2010.

Disclosure: No positions.